Evaluation of anti-hepatocarcinoma capacity of puerarin nanosuspensions against human HepG2 cells | |
Meng, Xiang -Ping[1]; Zhang, Zhen[2]; Wang, Yi-Fei[3]; Wang, Zhi-Ping[2]; Chen, Tong-Sheng[4,5] | |
会议日期 | JAN 30, 2017 |
会议地点 | San Francisco, CA |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4605636 |
专题 | 暨南大学 |
作者单位 | 1.[1]Henan Univ Sci & Technol, Med Technol & Engn Coll, Luoyang 471003, Peoples R China 2.[2]Guangdong Pharmaceut Univ, Sch Pharm, Guangzhou 510006, Guangdong, Peoples R China 3.[3]Jinan Univ, Inst Med Biol, Guangzhou 510632, Guangdong, Peoples R China 4.[4]South China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China 5.[5]South China Normal Univ, Inst Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Meng, Xiang -Ping[1],Zhang, Zhen[2],Wang, Yi-Fei[3],et al. Evaluation of anti-hepatocarcinoma capacity of puerarin nanosuspensions against human HepG2 cells[C]. 见:. San Francisco, CA. JAN 30, 2017. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论